Amundi
AXNX

Amundi’s Axonics, Inc. Common Stock AXNX Stock Holding History

Amundi’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-94,596
Closed -$6.59M – 2211
2024
Q3 		$6.59M Sell
94,596
-30,784
-25% -$2.11M ﹤0.01% 933
2024
Q2 		$8.47M Sell
125,380
-514,985
-80% -$34.7M ﹤0.01% 869
2024
Q1 		$42.9M Sell
640,365
-44,960
-7% -$3.03M 0.02% 556
2023
Q4 		$47.3M Sell
685,325
-14,592
-2% -$816K 0.02% 540
2023
Q3 		$37.1M Buy
699,917
+6,137
+0.9% +$345K 0.02% 568
2023
Q2 		$35.3M Buy
693,780
+24,175
+4% +$1.29M 0.02% 589
2023
Q1 		$37.9M Buy
669,605
+120,018
+22% +$7.01M 0.02% 564
2022
Q4 		$33.9M Buy
549,587
+175,387
+47% +$11.6M 0.02% 581
2022
Q3 		$28.7M Sell
374,200
-78,203
-17% -$5.39M 0.02% 620
2022
Q2 		$28.3M Sell
452,403
-22,018
-5% -$1.21M 0.02% 553
2022
Q1 		$30.4M Sell
474,421
-7,318
-2% -$394K 0.02% 577
2021
Q4 		$26.5M Buy
481,739
+133,741
+38% +$8.17M 0.02% 616
2021
Q3 		$22.7M Buy
347,998
+19,480
+6% +$1.33M 0.02% 661
2021
Q2 		$20.8M Buy
+328,518
New +$19.4M 0.01% 663

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amundi's AXNX Position: Q4 2024 in Review

Amundi sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 94,596 shares — an estimated $6.59M sold.

Amundi first reported a position in AXNX in Q2 2021 and held it in 14 quarters. The position peaked at $47.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Amundi reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Amundi sold 94,596 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $6.59M.
  • Amundi first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 14 quarters.
  • Amundi's Axonics, Inc. Common Stock position peaked at $47.3M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Amundi's 13F filing for Q4 2024, filed 7 Feb 2025.